Individual variation means some achieve more while others achieve less
More recently, encouraging clinical results from a triple-hormone-receptor agonist, Retatrutide, and several GLP-1R/GCGR dual agonists, suggest that GCGR could be a promising co-stimulating target for type 2 diabetes and obesity
Researchers presenting cross-trial Retatrutide vs Tirzepatide comparisons should note the different populations, trial durations, and statistical power levels
Are natural GLP-1s safe
From initial medical weight loss with medications like Semaglutide and Tirzepatide, through maintenance support, to final body contouring procedures that complete the transformation process and help patients achieve their ultimate aesthetic goals
Wegovy and Ozempic have become household names on social media, especially among those seeking dramatic weight loss